Press Releases
Washington, DC – The U.S. House of Representatives today approved legislation aimed at improving and speeding up the federal Food and Drug Administration's process for evaluating new over-the-counter (OTC) medications to determine whether they are safe enough to be sold to consumers without a prescription.
Washington, DC – Rep. Diana DeGette released the following statement after funding expired for nine federal departments and numerous agencies:
"Families in Colorado and across America should be enjoying the holiday season with their loved ones. Instead, this shutdown is forcing many to worry about their livelihoods during what should be a relaxing and celebratory time of year.
Washington, DC – Rep. Diana DeGette (CO-01) led 68 of her fellow House Democrats in submitting technical comments opposing an Environmental Protection Agency (EPA) proposal to weaken emissions standards for methane and other compounds.
Washington, DC -- Representatives. Diana DeGette (D-CO) and Fred Upton (R-MI) today released the following statement on the second anniversary of the 21st Century Cures Act being signed into law by President Barack Obama:
"21st Century Cures began with the spark of hope and continues today – pushing medical research in new and innovative ways.
Washington, DC – Today, Representatives Diana DeGette (CO-01) and Ed Perlmutter (CO-07) along with Colorado Senators Michael Bennet (D-CO) and Cory Gardner (R-CO) sent a letter to the Federal Railroad Administration (FRA), Denver Regional Transportation District (RTD), and Denver Transit Partners (DTP) urging continued cooperation in finalizing a plan of action to fix ongoing issues with grade crossings on the Eagle Project's commuter rail lines by the December 15 deadline.
Washington, D.C. – U.S. Representatives Diana DeGette's (D-CO) and Jaime Herrera Beutler's (R-WA) bipartisan bill to prevent maternal deaths passed the U.S. House by unanimous voice vote today.
Washington, DC -- Congressional Diabetes Caucus co-chairs Reps. Diana DeGette (D-CO) and Tom Reed (R-NY) issued the following statement after the FDA finalized guidance treating insulin as a biologic product:
Washington, DC – U.S. Senator Michael Bennet (D-CO) today led Colorado U.S. Representatives Diana DeGette, Ed Perlmutter, and Jared Polis, and Representatives-elect Joe Neguse and Jason Crow, in sending a letter to the Department of Homeland Security to object to the proposed rule expanding the definition of "public charge" under U.S. immigration law. The proposed rule would make permanent residence unavailable to individuals who rely on housing, health care, and food assistance, have a serious health condition, or earn a low income, among other factors.
Washington, DC— Congresswoman Diana DeGette (D-CO), a senior member of the Energy and Commerce Committee, joined fellow committee member, Congressman Larry Bucshon, M.D. (R-IN), and U.S. Senators Michael Bennet (D-CO) and Orrin Hatch (R-UT), members of the Senate Committee on Health, Education, Labor, and Pensions (HELP), in releasing draft legislation to establish a framework for overseeing in vitro clinical tests (IVCTs), such as test kits and laboratory developed tests (LDTs), at the Food and Drug Administration (FDA).
Washington, DC – Oversight and Investigations Ranking Member Diana DeGette (D-CO) joined fellow Democratic leaders on the Energy and Commerce Committee, Ranking Member Frank Pallone, Jr.